EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computational Workflow to Design Novel Vaccine Candidates and Small-Molecule Therapeutics for Schistosomiasis

Emmanuel Oluwadare Balogun iD, Gideon Ibrahim Joseph iD, Samuel Charles Olabode, Naziru Abdulkadir Dayaso iD, Ammar Usman Danazumi iD, Rachael Bashford-Rogers iD, James H Mckerrow, Ghulam Jeelani iD, Conor R Caffrey

Pathogens · 2024

DOI: 10.3390/pathogens13100850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Emmanuel Oluwadare Balogun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Ahmadu Bello University, Zaria 810001, Kaduna, Nigeria. Hauptthemen laut MEDLINE: Schistosomiasis, Molecular Docking Simulation, Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Terumo Life Science Foundation, Japan, Grant-in-Aid for Early-Career Scientists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human schistosomiasis, caused by the Schistosoma trematode, is a neglected parasitic disease affecting over 250 million people worldwide. There is no vaccine, and the single available drug is threatened by drug resistance. This study presents a computational approach to designing multiepitope vaccines (MEVs) targeting the cercarial (CMEV) and schistosomular (SMEV) stages of schistosomes, and identifies potential schistosomicidal compounds from the Medicine for Malaria Ventures (MMV) and SuperNatural Database (SND) libraries. The designed vaccines (CMEV and SMEV) are engineered to provoke robust immune responses by incorporating a blend of T- and B-cell epitopes. Structural and immunoinformatics evaluations predicted robust interactions of CMEV and SMEV with key immune receptors and prolonged immune responses. In addition, molecular docking identified several compounds from the MMV and SND libraries with strong binding affinities to vital Schistosoma cathepsin proteases, indicating their potential as schistosomicidal agents. Our findings contribute to the potential development of effective vaccines and drugs against schistosomiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchistosomiasisMolecular Docking SimulationVaccinesAnimalsHumansSchistosomaWorkflowComputational BiologyEpitopes, B-LymphocyteEpitopes, T-LymphocyteVaccine DevelopmentDrug DesignSmall Molecule Libraries

Stichwörter der Autor:innen

Schistosomacathepsin proteasesdrug and vaccineimmunoinformatics

Substanzen

VaccinesEpitopes, B-LymphocyteEpitopes, T-LymphocyteSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Biochemistry, Ahmadu Bello University, Zaria 810001, Kaduna, Nigeria.
  • Africa Center of Excellence for Neglected Tropical Diseases and Forensic Biotechnology (ACENTDFB), Ahmadu Bello University, Zaria 810001, Kaduna, Nigeria.
  • Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, MC0657, La Jolla, CA 92093, USA.
  • Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
  • Department of Biochemistry, Federal University of Technology, Minna PMB 65, Niger, Nigeria.
  • Africa Centre of Excellence for Mycotoxin and Food Safety, Federal University of Technology, Minna PMB 65, Niger, Nigeria.

ORCID-Profile: Emmanuel Oluwadare Balogun, Gideon Ibrahim Joseph, Naziru Abdulkadir Dayaso, Ammar Usman Danazumi, Rachael Bashford-Rogers, Ghulam Jeelani

Förderung

  • FIC NIH HHS
  • Terumo Life Science Foundation, Japan
  • Grant-in-Aid for Early-Career Scientists
  • Fogarty International Center of the National Institutes of Health

Zitieren

APA

Balogun, E. O., Joseph, G. I., Olabode, S. C., Dayaso, N. A., Danazumi, A. U., Bashford-Rogers, R., Mckerrow, J. H., Jeelani, G., & Caffrey, C. R. (2024). Computational Workflow to Design Novel Vaccine Candidates and Small-Molecule Therapeutics for Schistosomiasis. Pathogens. https://doi.org/10.3390/pathogens13100850

Vancouver

Balogun EO, Joseph GI, Olabode SC, Dayaso NA, Danazumi AU, Bashford-Rogers R, et al. Computational Workflow to Design Novel Vaccine Candidates and Small-Molecule Therapeutics for Schistosomiasis. Pathogens. 2024. doi:10.3390/pathogens13100850

BibTeX
@article{Balogun2024,
  author = {Balogun, Emmanuel Oluwadare and Joseph, Gideon Ibrahim and Olabode, Samuel Charles and Dayaso, Naziru Abdulkadir and Danazumi, Ammar Usman and Bashford-Rogers, Rachael and Mckerrow, James H and Jeelani, Ghulam and Caffrey, Conor R},
  title = {Computational Workflow to Design Novel Vaccine Candidates and Small-Molecule Therapeutics for Schistosomiasis},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13100850}
}
Kostenlos starten →